Moleculin Biotech, Inc.
MBRX
$0.9502
$0.07538.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.28% | -16.23% | -15.47% | -16.89% | -13.23% |
| Depreciation & Amortization | -2.34% | 3.20% | 4.00% | 1.56% | -1.54% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.09% | 4.16% | -10.26% | -12.42% | -3.29% |
| Operating Income | 10.09% | -4.16% | 10.26% | 12.42% | 3.29% |
| Income Before Tax | 26.89% | -14.77% | 14.02% | 10.80% | -2.56% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 26.89% | -14.77% | 14.02% | 10.80% | -2.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.89% | -14.77% | 14.02% | 10.80% | -2.56% |
| EBIT | 10.09% | -4.16% | 10.26% | 12.42% | 3.29% |
| EBITDA | 10.13% | -4.16% | 10.31% | 12.48% | 3.30% |
| EPS Basic | 53.92% | 13.80% | 23.57% | 17.79% | 1.06% |
| Normalized Basic EPS | 53.92% | 13.80% | 23.57% | 17.79% | 1.06% |
| EPS Diluted | 53.92% | 13.80% | 23.57% | 17.79% | 1.06% |
| Normalized Diluted EPS | 53.92% | 13.80% | 23.57% | 17.79% | 1.06% |
| Average Basic Shares Outstanding | 74.18% | 37.87% | 16.88% | 10.63% | 3.59% |
| Average Diluted Shares Outstanding | 74.18% | 37.87% | 16.88% | 10.63% | 3.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |